Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
Belite Bio, Inc. ADR (BLTE) Stock Price & Analysis
3 Followers
BLTE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$14.22 - $44.70
Previous Close$16.49
Volume575.08K
Average Volume (3M)20.83K
Market Cap
$596.24M
Enterprise Value$555.02M
Total Cash (Recent Filing)$42.09M
Total Debt (Recent Filing)$866.00K
Price to Earnings (P/E)N/A
Beta-0.67
Next Earnings
Aug 09, 2023EPS Estimate
-$0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding24,898,908
10 Day Avg. Volume15,780
30 Day Avg. Volume20,833
Standard Deviation0.33
R-Squared0.17
Alpha0.13
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$57.50Price Target Upside248.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Belite Bio, Inc. ADR News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BLTE FAQ
What was Belite Bio, Inc. ADR’s price range in the past 12 months?
Belite Bio, Inc. ADR lowest stock price was $14.22 and its highest was $44.70 in the past 12 months.
What is Belite Bio, Inc. ADR’s market cap?
Currently, no data Available
When is Belite Bio, Inc. ADR’s upcoming earnings report date?
Belite Bio, Inc. ADR’s upcoming earnings report date is Aug 09, 2023 which is in 69 days.
How were Belite Bio, Inc. ADR’s earnings last quarter?
Currently, no data Available
Is Belite Bio, Inc. ADR overvalued?
According to Wall Street analysts Belite Bio, Inc. ADR’s price is currently Undervalued.
Does Belite Bio, Inc. ADR pay dividends?
Belite Bio, Inc. ADR does not currently pay dividends.
What is Belite Bio, Inc. ADR’s EPS estimate?
Belite Bio, Inc. ADR’s EPS estimate is -$0.18.
How many shares outstanding does Belite Bio, Inc. ADR have?
Belite Bio, Inc. ADR has 24,898,909 shares outstanding.
What happened to Belite Bio, Inc. ADR’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Belite Bio, Inc. ADR?
Currently, no hedge funds are holding shares in BLTE
---
Belite Bio, Inc. ADR Stock Smart Score
Learn more about TipRanks Smart Score
Company Description
Belite Bio, Inc. ADR
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
---
Top 5 ETFs holding BLTE
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold BLTE. The ETFs are listed according to market value of BLTE within the ETF
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---